Share price
₹360.65 latest close · −34.6% over the last 90 sessions
₹360.65 month-end · −1.9% over 12 months
₹360.65 month-end · +130.3% over 3 years
₹360.65 month-end · +227.6% since Jan '19
52-week range ₹292.40 to ₹647.00 · 1-year volatility 55.2%
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-75.5% (2021-05 peak to 2023-03 low, recovered 2024-11)
-53.0% (2019-04 peak to 2020-03 low, recovered 2020-06)
-49.5% (2026-06 peak to 2026-10 low, not yet recovered)
Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).
Where does it rank among Health Technology peers?
Each cell is the company's percentile rank among its Health Technology peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE8th▲ 3 pts vs a year ago
- Op. margin11thflat vs a year ago
- Revenue growth46th▼ 18 pts vs a year ago
- EPS growth5th
- Debt/equity ↓82ndflat vs a year ago
- Cash cycle ↓90thflat vs a year ago
- P/E ↓4th
- 12M momentum38th▼ 11 pts vs a year ago
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Technology sector page Watch it move against Health Technology in the Observatory
What is the price implying?
Trailing earnings per share are negative, so a P/E-based figure does not exist. See the loss-makers list on the Expectations Gap page for a revenue-based version.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Technology The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹360.65
- ROCE
- -2.0%
- Market Cap
- ₹2211 cr
- Revenue (TTM)
- ₹673 cr
- P/S
- 3.3x
- P/B
- 2.6x
- ROE
- -0.9%
- Operating Margin
- 2.8%
- Debt / Equity
- 0.0x
- Promoter Holding
- 72.5%
- 12M Momentum
- -1.9%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance—Not enough data
Not enough reported data to compute this.
Tax rate—Not enough data
Not enough reported data to compute this.
Cash conversion—Not enough data
Not enough reported data to compute this.
Free cash flow0 of 5 yrsBeyond threshold
Fiscal years with positive free cash flow in the last 5: 0. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history-5 daysWithin range
Debtor days are below the median of the previous three fiscal years by 5 days (42 vs 47). Bands: under 15 days, 15 to 45, over 45.
Capital work in progress25% of fixed assetsWithin range
Capital work-in-progress is 25% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days+3 days / 2 yrsWithin range
Days payable changed by +3 over two years. Bands: rise of up to 30 days; more than 30 days.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Over 3 years, FIIs added 2.0 pts; DIIs added 1.7 pts; promoters trimmed 1.1 pts.
- The number of shareholders fell from 48,878 to 33,532 (-31%) between Sep 2023 and Jun 2026.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like PANACEA BIOTEC LTD today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −32% to −1% vs the market, against −5% for all non-financial companies in the same months.
- The analogs' median sat below that base rate (gap −12.5%, 80% range −21.4% to −10.1%), but the matches cluster in only 6 distinct 12-month windows.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 2 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 33 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| DWARKESH Process Industries |
Nov 2020 | — | — | +21% | −29% | +59% |
| UNICHEMLAB Health Technology |
Jun 2023 | — | -5% | +56% | −19% | −3% |
| ASIANTILES Producer Manufacturing |
May 2025 | — | 1% | +3% | −36% | −1% |
| SEPC Industrial Services |
Apr 2024 | — | -3% | +84% | −27% | −26% |
| GOLDTECH Technology Services |
Jul 2024 | — | -1% | +39% | −19% | −41% |
Show the other 3 matches
How reliable is this?
Matched on P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, ROCE and drawdown from 12-month high. Not used (unavailable for this company): P/E. This company is loss-making, so it was only compared with loss-making companies. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 6 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What changed?
30 events since Jun '21
- OctPriceFell 50% from the Jun 2026 peak to the Oct 2026 low.
- SepResultsRevenue (TTM) reached a new high of ₹673 cr.
- JunPriceRegained the 2025-05 peak, 3 months after the low.
- JunPriceVolume reached 131.1x its 50-day median on 2026-06-09; price +9.9% that day.
- MarPriceFell 48% from the May 2025 peak to the Mar 2026 low.
- JanPriceVolume reached 181.7x its 50-day median on 2026-01-08; price +12.6% that day.
- DecResultsEPS (TTM) turned negative.
- DecPriceVolume reached 322.4x its 50-day median on 2025-12-26; price +13.4% that day.
Show 22 earlier events
- SepResultsEPS (TTM) turned positive.
- AugPriceVolume reached 8.6x its 50-day median on 2025-08-29; price +9.7% that day.
- AprPriceRegained the 2024-12 peak, 2 months after the low.
- MarPriceVolume reached 10.0x its 50-day median on 2025-03-20; price +4.4% that day.
- FebPriceFell 39% from the Dec 2024 peak to the Feb 2025 low.
- NovPriceRegained the 2021-05 peak, 20 months after the low.
- AugPriceVolume reached 29.1x its 50-day median on 2024-08-14; price +3.9% that day.
- JunPriceVolume reached 6.2x its 50-day median on 2024-06-27; price -3.5% that day.
- JanPriceVolume reached 10.4x its 50-day median on 2024-01-03; price +9.5% that day.
- DecPriceVolume reached 6.8x its 50-day median on 2023-12-26; price +8.7% that day.
- SepPriceVolume reached 132.3x its 50-day median on 2023-09-18; price +13.1% that day.
- JunPriceVolume reached 19.5x its 50-day median on 2023-06-13; price +5.0% that day.
- MarPriceFell 76% from the May 2021 peak to the Mar 2023 low.
- FebPriceVolume reached 10.4x its 50-day median on 2023-02-14; price +6.0% that day.
- OctPriceVolume reached 43.7x its 50-day median on 2022-10-11; price +18.1% that day.
- AugPriceVolume reached 16.6x its 50-day median on 2022-08-02; price +11.1% that day.
- JunResultsRevenue (TTM) reached a new high of ₹661 cr.
- MayPriceVolume reached 10.3x its 50-day median on 2022-05-19; price +4.8% that day.
- FebPriceVolume reached 7.4x its 50-day median on 2022-02-03; price -5.0% that day.
- DecPriceVolume reached 5.6x its 50-day median on 2021-12-01; price -3.5% that day.
- SepPriceVolume reached 11.0x its 50-day median on 2021-09-07; price +9.2% that day.
- JunResultsRevenue (TTM) reached a new high of ₹625 cr.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history95 months · 2019-01 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | — | ₹673 cr | -0.9% | -2.0% | 0.0x |
| 2026-10 | — | ₹673 cr | -0.9% | -2.0% | 0.0x |
| 2026-09 | — | ₹673 cr | -0.9% | -2.0% | 0.0x |
| 2026-08 | — | ₹640 cr | -0.7% | -2.0% | 0.0x |
| 2026-07 | — | ₹640 cr | -0.7% | -2.0% | 0.0x |
| 2026-06 | — | ₹640 cr | -0.7% | -2.0% | 0.0x |
| 2026-05 | — | ₹606 cr | -0.8% | -5.0% | 0.0x |
| 2026-04 | — | ₹606 cr | -0.8% | -5.0% | 0.0x |
| 2026-03 | — | ₹606 cr | -0.8% | -5.0% | 0.0x |
| 2026-02 | — | ₹604 cr | -0.7% | -5.0% | 0.0x |
| 2026-01 | — | ₹604 cr | -0.7% | -5.0% | 0.0x |
| 2025-12 | — | ₹604 cr | -0.7% | -5.0% | 0.0x |
| 2025-11 | 196.6x | ₹610 cr | 1.1% | -5.0% | 0.0x |
| 2025-10 | 234.2x | ₹610 cr | 1.1% | -5.0% | 0.0x |
| 2025-09 | 217.6x | ₹610 cr | 1.1% | -5.0% | 0.0x |
| 2025-08 | — | ₹559 cr | -0.8% | -5.0% | 0.0x |
| 2025-07 | — | ₹559 cr | -0.8% | -5.0% | 0.0x |
| 2025-06 | — | ₹559 cr | -0.8% | -5.0% | 0.0x |
| 2025-05 | — | ₹563 cr | -0.8% | -4.0% | 0.0x |
| 2025-04 | — | ₹563 cr | -0.8% | -4.0% | 0.0x |
| 2025-03 | — | ₹563 cr | -0.8% | -4.0% | 0.0x |
| 2025-02 | — | ₹550 cr | -1.5% | -4.0% | 0.0x |
| 2025-01 | — | ₹550 cr | -1.5% | -4.0% | 0.0x |
| 2024-12 | — | ₹550 cr | -1.5% | -4.0% | 0.0x |
| 2024-11 | — | ₹546 cr | -2.7% | -4.0% | 0.0x |
| 2024-10 | — | ₹546 cr | -2.7% | -4.0% | 0.0x |
| 2024-09 | — | ₹546 cr | -2.7% | -4.0% | 0.0x |
| 2024-08 | — | ₹559 cr | -0.2% | -4.0% | 0.0x |
| 2024-07 | — | ₹559 cr | -0.2% | -4.0% | 0.0x |
| 2024-06 | — | ₹559 cr | -0.2% | -4.0% | 0.0x |
| 2024-05 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2024-04 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2024-03 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2024-02 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2024-01 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-12 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-11 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-10 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-09 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-08 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-07 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-06 | — | ₹460 cr | -3.2% | -10.0% | 0.0x |
| 2023-05 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2023-04 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2023-03 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2023-02 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2023-01 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-12 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-11 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-10 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-09 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-08 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-07 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-06 | — | ₹661 cr | 98.0% | -6.0% | 0.0x |
| 2022-05 | — | ₹625 cr | — | 5.0% | — |
| 2022-04 | — | ₹625 cr | — | 5.0% | — |
| 2022-03 | — | ₹625 cr | — | 5.0% | — |
| 2022-02 | — | ₹625 cr | — | 5.0% | — |
| 2022-01 | — | ₹625 cr | — | 5.0% | — |
| 2021-12 | — | ₹625 cr | — | 5.0% | — |
| 2021-11 | — | ₹625 cr | — | 5.0% | — |
| 2021-10 | — | ₹625 cr | — | 5.0% | — |
| 2021-09 | — | ₹625 cr | — | 5.0% | — |
| 2021-08 | — | ₹625 cr | — | 5.0% | — |
| 2021-07 | — | ₹625 cr | — | 5.0% | — |
| 2021-06 | — | ₹625 cr | — | 5.0% | — |
| 2021-05 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2021-04 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2021-03 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2021-02 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2021-01 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-12 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-11 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-10 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-09 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-08 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-07 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-06 | — | ₹544 cr | -77.7% | 5.0% | 3.7x |
| 2020-05 | 18.0x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2020-04 | 20.8x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2020-03 | 13.2x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2020-02 | 12.9x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2020-01 | 15.7x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-12 | 15.8x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-11 | 15.1x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-10 | 16.9x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-09 | 17.4x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-08 | 15.8x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-07 | 14.9x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-06 | 18.9x | ₹457 cr | 8.7% | -16.0% | 1.8x |
| 2019-05 | — | ₹593 cr | -19.6% | 3.0% | 3.0x |
| 2019-04 | — | ₹593 cr | -19.6% | 3.0% | 3.0x |
| 2019-03 | — | ₹593 cr | -19.6% | 3.0% | 3.0x |
| 2019-02 | — | ₹593 cr | -19.6% | 3.0% | 3.0x |
| 2019-01 | — | ₹593 cr | -19.6% | 3.0% | 3.0x |